Neoadjuvant Chemoradiotherapy Combined With PD-1 Antibody in Locally Advanced Esophageal Cancer

NCT04177875 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
44
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Tongji Hospital